Hisamitsu Pharmaceutical's (TSE:4530) Solid Earnings May Rest On Weak Foundations

Simply Wall St · 10/17 21:08

Hisamitsu Pharmaceutical Co., Inc.'s (TSE:4530) healthy profit numbers didn't contain any surprises for investors. We think this is due to investors looking beyond the statutory profits and being concerned with what they see.

See our latest analysis for Hisamitsu Pharmaceutical

earnings-and-revenue-history
TSE:4530 Earnings and Revenue History October 17th 2024

The Impact Of Unusual Items On Profit

Importantly, our data indicates that Hisamitsu Pharmaceutical's profit received a boost of JP¥1.9b in unusual items, over the last year. We can't deny that higher profits generally leave us optimistic, but we'd prefer it if the profit were to be sustainable. We ran the numbers on most publicly listed companies worldwide, and it's very common for unusual items to be once-off in nature. Which is hardly surprising, given the name. If Hisamitsu Pharmaceutical doesn't see that contribution repeat, then all else being equal we'd expect its profit to drop over the current year.

That might leave you wondering what analysts are forecasting in terms of future profitability. Luckily, you can click here to see an interactive graph depicting future profitability, based on their estimates.

Our Take On Hisamitsu Pharmaceutical's Profit Performance

We'd posit that Hisamitsu Pharmaceutical's statutory earnings aren't a clean read on ongoing productivity, due to the large unusual item. Therefore, it seems possible to us that Hisamitsu Pharmaceutical's true underlying earnings power is actually less than its statutory profit. But at least holders can take some solace from the 51% per annum growth in EPS for the last three. Of course, we've only just scratched the surface when it comes to analysing its earnings; one could also consider margins, forecast growth, and return on investment, among other factors. So if you'd like to dive deeper into this stock, it's crucial to consider any risks it's facing. You'd be interested to know, that we found 1 warning sign for Hisamitsu Pharmaceutical and you'll want to know about this.

Today we've zoomed in on a single data point to better understand the nature of Hisamitsu Pharmaceutical's profit. But there is always more to discover if you are capable of focussing your mind on minutiae. For example, many people consider a high return on equity as an indication of favorable business economics, while others like to 'follow the money' and search out stocks that insiders are buying. So you may wish to see this free collection of companies boasting high return on equity, or this list of stocks with high insider ownership.